Ignite Creation Date:
2025-12-24 @ 10:51 PM
Ignite Modification Date:
2025-12-28 @ 8:30 AM
Study NCT ID:
NCT05947669
Status:
RECRUITING
Last Update Posted:
2023-08-24
First Post:
2023-06-14
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy and Safety of Infliximab for Immune Checkpoint Inhibitor Induced Colitis
Sponsor:
Odense University Hospital
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
The ICaD Study
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None